CA
ROIV icon

Cliff Asness’s Roivant Sciences ROIV Stock Holding History

Cliff Asness’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$234M Buy
6,633,560
+686,702
+12% +$20.3M 0.08% 338
2026
Q1 		$162M Buy
5,946,858
+5,066,085
+575% +$130M 0.07% 355
2025
Q4 		$19M Buy
880,773
+810,402
+1,152% +$16M 0.01% 954
2025
Q3 		$1.06M Buy
+70,371
New +$871K ﹤0.01% 2400
2024
Q4 		– Sell
-131,422
Closed -$1.51M – 2936
2024
Q3 		$1.51M Sell
131,422
-73,512
-36% -$837K ﹤0.01% 1630
2024
Q2 		$2.17M Sell
204,934
-96,894
-32% -$1.06M ﹤0.01% 1424
2024
Q1 		$3.15M Buy
301,828
+214,884
+247% +$2.32M 0.01% 1210
2023
Q4 		$974K Sell
86,944
-27,665
-24% -$270K ﹤0.01% 1610
2023
Q3 		$1.34M Buy
114,609
+7,489
+7% +$84.7K ﹤0.01% 1489
2023
Q2 		$1.08M Buy
+107,120
New +$958K ﹤0.01% 1521

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Cliff Asness's ROIV Position: Q2 2026 in Review

Cliff Asness increased its Roivant Sciences (ROIV) stake by 12% in Q2 2026, buying an estimated $20.3M and bringing the position to 6,633,560 shares worth $234M. The position accounts for 0.08% of the portfolio, ranked #338.

Cliff Asness first reported a position in ROIV in Q2 2023 and has held it in 10 quarters since. 495 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Cliff Asness held 6,633,560 shares of Roivant Sciences worth $234M as of Q2 2026.
  • Cliff Asness bought 686,702 Roivant Sciences shares in Q2 2026, an estimated $20.3M.
  • Roivant Sciences made up 0.08% of Cliff Asness's portfolio in Q2 2026, its #338 holding.
  • Cliff Asness first reported a position in Roivant Sciences in Q2 2023 and has held it in 10 quarters since.
  • 495 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.